Performance-driven, pulmonary delivery of systemically acting drugs

Area of Science:

• Pharmacology
• Drug Delivery
• Respiratory Medicine

Background:

• Systemic drug delivery via inhalation aerosols requires efficient delivery to the lung's alveolar region.
• Advanced inhaler technologies improve deep lung drug administration.
• Lung clearance mechanisms significantly reduce drug bioavailability.

Purpose of the Study:

• To investigate methods for enhancing drug absorption from the lung.
• To review strategies for accelerating drug transport across respiratory epithelia.
• To explore approaches for decreasing local drug degradation in the lung.

Main Methods:

• Literature review of recent advancements in inhalation aerosol technology.
• Analysis of strategies to overcome lung clearance mechanisms.
• Examination of methods to enhance drug permeation and stability in lung tissue.

Main Results:

• High-technology inhalers enhance deep lung drug delivery.
• Lung clearance mechanisms remain a significant barrier to bioavailability.
• Strategies focus on improving epithelial transport and reducing enzymatic degradation.

Conclusions:

• Enhancing drug absorption in the lung is crucial for effective systemic delivery.
• Targeted strategies can improve drug bioavailability by addressing epithelial barriers and degradation.
• Further research into novel delivery systems and formulation approaches is warranted.